Ibandronic acid

• CAT Number: I000530
• CAS Number: 114084-78-5
• Molecular Formula: C9H23NO7P2
• Molecular Weight: 319.23
• Purity: ≥95%
• Target: Others
• Solubility: 10 mM in DMSO
• Storage: 3 years -20C powder
• IUPAC Name: [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid
• InChI: InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17)
• InChIKey: MPBVHIBUJCELCL-UHFFFAOYSA-N
• SMILES: CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O

Ibandronic acid（Cat No.:I000530）is a bisphosphonate medication primarily used to treat osteoporosis, particularly in postmenopausal women, and to prevent bone complications in patients with metastatic breast cancer. It works by inhibiting osteoclast-mediated bone resorption, which helps increase bone mineral density and reduce the risk of fractures. Ibandronic acid is typically administered either orally or via intravenous injection, depending on the clinical scenario. Common side effects include gastrointestinal issues, musculoskeletal pain, and, rarely, osteonecrosis of the jaw. Its use is carefully monitored, especially in patients with kidney impairment or a history of bone diseases.